William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
View Older Stories View More Recent Stories
-
Poshmark Inc. (POSH) Prices 6.6M Share IPO at $42/Sh
-
Poshmark, Inc. Announces Pricing of Initial Public Offering
-
REPAY Announces Pricing of Public Offering of Common Stock
-
Lemonade Announces Upsizing and Pricing of Public Offering of Common Stock
-
William Blair Downgrades VMware (VMW) to Market Perform
-
K1 Agrees to Sell Clarizen, the Category Leader in Enterprise Collaborative Work Management, to Planview
-
Analysis: The trillion dollar weapon in the U.S.-China tech stock war
-
Franchise Group, Inc. Prices $75 Million Offering of Series A Cumulative Perpetual Preferred Stock
-
loanDepot Files Registration Statement for Proposed Initial Public Offering
-
DermTech Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Franchise Group, Inc. Announces Offering of Series A Cumulative Perpetual Preferred Stock
-
Form SC 13G Star Peak Energy Transit Filed by: WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
-
Duff & Phelps Investment Management Names David Grumhaus President and Chief Investment Officer
-
Sana Biotechnology Announces Appointments to its Board of Directors
-
Driven Brands Holdings Inc. (DRVN) Announces Proposed 38M Share IPO Between $17-$20/Sh
-
Driven Brands Holdings Inc. Announces Launch of Initial Public Offering
-
Driven Brands Holdings Inc. Announces Launch of Initial Public Offering
-
DermTech (DMTK) Prices 4.237M Share Common Offering at $29.50/Sh
-
DermTech Announces Pricing of Public Offering of Common Stock
-
DermTech (DMTK) Announces Proposed Public Offering of Common Stock
-
DermTech Announces Proposed Public Offering of Common Stock
-
Serán Bioscience Announces Investment by Vivo Capital
-
THL Completes Sale of 50% Stake in CSafe Global to Frazier Healthcare Partners
-
Form D William Blair U.S. Equit
-
Clearlake Capital And Aurora Capital-Backed Zywave Acquires Insurance Technologies Corporation (ITC)
-
Wall Street Initiates Coverage of DoorDash (DASH) with Mixed Ratings Amid 'Premium' Valuation
-
Green Garden Products to Be Acquired by Central Garden & Pet
-
Central Garden & Pet Company (CENTA) To Acquire Green Garden for $532M
-
Central Garden & Pet To Acquire Green Garden
-
Form 40-17G WILLIAM BLAIR FUNDS
-
PointClickCare Technologies Announces Closing of Collective Medical Acquisition
-
Youth INC Distributes $1 Million in COVID-19 Response and Recovery Grants to Nonprofit Partners
-
Revelstoke Completes Sale of ONsite Mammography
-
Form D/A William Blair Global
-
BioMedNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN) Closes $100M Underwritten Public Offering
-
Datasite Completes Agreement to be Acquired by CapVest
-
TSG Consumer Partners Announces Promotions
-
908 Devices Announces Closing of Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
-
Alta Equipment Group Inc. Closes Offering of Series A Cumulative Perpetual Preferred Stock
-
VistaGen Therapeutics Announces Closing of $100 Million Underwritten Public Offering
-
VistaGen Therapeutics Announces Closing of $100 Million Underwritten Public Offering
-
XOMA Announces Exercise of Green Shoe Option and Closes Preferred Stock Offering
-
William Blair Downgrades HMS Holdings (HMSY) to Market Perform, Following Acquisition
-
Ontrak Announces Closing of Follow-On Offering of Non-Convertible Preferred Stock
-
908 Devices (MASS) IPO Opens 128% Higher
-
Alta Equipment Group Inc. Prices $30 Million Offering of Series A Cumulative Perpetual Preferred Stock
-
UPDATE: William Blair Initiates on Snowflake Inc. (SNOW) with MP, Explains the "Significant Downside" Risk
-
908 Devices Inc. (MASS) Prices 6.5M Share IPO at $20/Share
-
VistaGen Therapeutics (VTGN) Prices Underwritten Public Offering of Common Stock, Conv. Preferred Stock
-
VistaGen Therapeutics Announces Pricing of Underwritten Public Offering

